Agency Forms Undergoing Paperwork Reduction Act Review, 40703-40704 [2016-14724]

Download as PDF Federal Register / Vol. 81, No. 120 / Wednesday, June 22, 2016 / Notices Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2016–14725 Filed 6–21–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention mstockstill on DSK3G9T082PROD with NOTICES Healthcare Infection Control Practices Advisory Committee (HICPAC) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following meeting for the aforementioned committee: Times and Dates: 9:00 a.m.–5:00 p.m., EDT, July 14, 2016; 9:00 a.m.–12:00 p.m., EDT, July 15, 2016. Place: Centers for Disease Control and Prevention, Global Communications Center, Building 19, Auditorium B, 1600 Clifton Road NE., Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 300 people. Please register for the meeting at www.cdc.gov/hicpac. Purpose: The Committee is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion, the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health and Human Services regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters for Discussion: The agenda will include updates on CDC’s activities for prevention of healthcare associated infections (HAIs), updates on antimicrobial stewardship, an update on Draft Guideline for Prevention of Infections in Healthcare Personnel, and an update from the workgroup for considerations on endoscope reprocessing. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Erin Stone, M.S., HICPAC, Division of VerDate Sep<11>2014 20:02 Jun 21, 2016 Jkt 238001 40703 Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE., Mailstop A–07, Atlanta, Georgia 30333 Telephone (404) 639–4045, Email: hicpac@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Proposed Project Health Risks from Using Private Wells for Drinking Water—New — National Center for Environmental Health (NCEH), Centers for Disease Control and Prevention (CDC). [FR Doc. 2016–14788 Filed 6–21–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–16–16TL] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 Background and Brief Description The Safe Drinking Water Act of 1974 (SDWA) ensures that most Americans are provided access to water that meets established public health standards. However, for over 38 million Americans who rely on private wells or other drinking water not protected by the SDWA (herein referred to as private wells), that is not the case. There is no comprehensive knowledge about the locations of private wells, the populations served by these sources, potential contaminants that might be present in private well water in specific areas of the country, or the potential health risks associated with drinking water from these sources. The purpose of this new generic clearance information collection request is to assess the health risks associated with exposure to contaminants in drinking water from private wells across varied geographic areas of the United States in partnership with the requesting agency (state, territorial, local, or tribal health department). The information obtained from these investigations will be used to describe health risks from exposure to contaminants in drinking water from private wells within a defined time period and geographic distribution. This information will be used to inform public health protection activities conducted by the requesting agencies. The respondents are defined as adults at least 18 years old, who use private wells for drinking water, who are willing to receive and return a tap water sampling kit and urine specimen kit or to provide a blood specimen, and who are willing to answer survey questions. They will be recruited from geographic areas of interest as defined by the requesting agency. Based on our historical activities, we estimate that CDC will conduct up to 10 E:\FR\FM\22JNN1.SGM 22JNN1 40704 Federal Register / Vol. 81, No. 120 / Wednesday, June 22, 2016 / Notices investigations per year. Each investigation will involve on average 200 respondents. The total time burden is 2,084 hours. There will be no cost to the respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Number of responses per respondent Average burden per response (in hrs.) Type of respondents Form name Adult at least 18 years old using a private well for tap water. Screening Form .............................................. 2,500 1 6/60 Questionnaire ................................................. Urine Specimen and Tap Water Sample Collection. 2,000 2,000 1 1 35/60 20/60 Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. OMB. FDA is withdrawing the proposed collection of information that published on June 2, 2016, at this time. [FR Doc. 2016–14724 Filed 6–21–16; 8:45 am] Dated: June 16, 2016. Leslie Kux, Associate Commissioner for Policy. BILLING CODE 4163–18–P [FR Doc. 2016–14722 Filed 6–21–16; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Health Resources and Services Administration [Docket No. FDA–2013–D–1543] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Nonproprietary Naming of Biological Products; Withdrawal AGENCY: Food and Drug Administration, HHS. ACTION: This document withdraws a Food and Drug Administration (FDA) notice that published in the Federal Register of June 2, 2016 (81 FR 35367). DATES: This notice is withdrawn on June 22, 2016. FOR FURTHER INFORMATION CONTACT: Howard Muller, Center for Drug Evaluation and Research (CDER), 10903 New Hampshire Ave., Bldg. 51, Rm. 6234, Silver Spring, MD 20993–0002, 301–796–3474. SUPPLEMENTARY INFORMATION: FDA published a notice in the Federal Register of June 2, 2016, informing interested parties that the proposed collection of information entitled ‘‘Guidance for Industry on Nonproprietary Naming of Biological Products’’ had been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 and inviting the public to submit comments on the proposed collection to mstockstill on DSK3G9T082PROD with NOTICES VerDate Sep<11>2014 20:02 Jun 21, 2016 Jkt 238001 Health Resources and Services Administration, HHS. ACTION: Notice. AGENCY: In compliance with the requirement for opportunity for public comment on proposed data collection projects (section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995), the Health Resources and Services Administration (HRSA) announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate, below, or any other aspect of the ICR. DATES: Comments on this ICR should be received no later than August 22, 2016. ADDRESSES: Submit your comments to paperwork@hrsa.gov or mail the HRSA Information Collection Clearance Officer, Room 14N–39, 5600 Fishers Lane, Rockville, MD 20857. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the data collection plans and draft instruments, email paperwork@hrsa.gov SUMMARY: Withdrawal of notice. SUMMARY: Agency Information Collection Activities: Proposed Collection: Public Comment Request PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 or call the HRSA Information Collection Clearance Officer at (301) 443–1984. When submitting comments or requesting information, please include the information request collection title for reference. SUPPLEMENTARY INFORMATION: Information Collection Request Title: Data Collection Tool for State Offices of Rural Health Grant Program OMB No. 0915–0322—Extension Abstract: The mission of the Federal Office of Rural Health Policy (FORHP) is to sustain and improve access to quality care services for rural communities. In its authorizing language (section 711 of the Social Security Act [42 U.S.C. 912]), Congress charged FORHP with administering grants, cooperative agreements, and contracts to provide technical assistance and other activities as necessary to support activities related to improving health care in rural areas. In accordance with the Public Health Service Act, section 338J (42 U.S.C. 254r), HRSA proposes to continue the State Offices of Rural Health (SORH) Grant Program— Funding Opportunity Announcement (FOA) and Forms for the Application. The FOA is used by 50 states in preparing applications for grants under the SORH Grant Program of the Public Health Service Act, and in preparing the required report. Need and Proposed Use of the Information: FORHP seeks to continue gathering information from grantees on their efforts to provide technical assistance to clients within their states. SORH grantees submit a Technical Assistance Report that includes: (1) The total number of technical assistance encounters provided directly by the grantee, and (2) the total number of unduplicated clients that received direct technical assistance from the grantee. The Technical Assistance Report is submitted via the HRSA Electronic E:\FR\FM\22JNN1.SGM 22JNN1

Agencies

[Federal Register Volume 81, Number 120 (Wednesday, June 22, 2016)]
[Notices]
[Pages 40703-40704]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-14724]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-16-16TL]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to omb@cdc.gov. Direct written comments 
and/or suggestions regarding the items contained in this notice to the 
Attention: CDC Desk Officer, Office of Management and Budget, 
Washington, DC 20503 or by fax to (202) 395-5806. Written comments 
should be received within 30 days of this notice.

Proposed Project

    Health Risks from Using Private Wells for Drinking Water--New -- 
National Center for Environmental Health (NCEH), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    The Safe Drinking Water Act of 1974 (SDWA) ensures that most 
Americans are provided access to water that meets established public 
health standards. However, for over 38 million Americans who rely on 
private wells or other drinking water not protected by the SDWA (herein 
referred to as private wells), that is not the case. There is no 
comprehensive knowledge about the locations of private wells, the 
populations served by these sources, potential contaminants that might 
be present in private well water in specific areas of the country, or 
the potential health risks associated with drinking water from these 
sources.
    The purpose of this new generic clearance information collection 
request is to assess the health risks associated with exposure to 
contaminants in drinking water from private wells across varied 
geographic areas of the United States in partnership with the 
requesting agency (state, territorial, local, or tribal health 
department). The information obtained from these investigations will be 
used to describe health risks from exposure to contaminants in drinking 
water from private wells within a defined time period and geographic 
distribution. This information will be used to inform public health 
protection activities conducted by the requesting agencies.
    The respondents are defined as adults at least 18 years old, who 
use private wells for drinking water, who are willing to receive and 
return a tap water sampling kit and urine specimen kit or to provide a 
blood specimen, and who are willing to answer survey questions. They 
will be recruited from geographic areas of interest as defined by the 
requesting agency.
    Based on our historical activities, we estimate that CDC will 
conduct up to 10

[[Page 40704]]

investigations per year. Each investigation will involve on average 200 
respondents. The total time burden is 2,084 hours. There will be no 
cost to the respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
          Type of respondents                   Form name           respondents    responses per   response (in
                                                                                    respondent         hrs.)
----------------------------------------------------------------------------------------------------------------
Adult at least 18 years old using a     Screening Form..........           2,500               1            6/60
 private well for tap water.
                                        Questionnaire...........           2,000               1           35/60
                                        Urine Specimen and Tap             2,000               1           20/60
                                         Water Sample Collection.
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-14724 Filed 6-21-16; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.